|
|
|
XIIth International Myeloma Workshop, Day 2, February 27, 2009
- 07:00-08:00 Current Approaches to Supportive Care in Myeloma – Breakfast Symposium (Sponsored by Celgene)
- 08:15-10:15 Multiple Myeloma Microenvironment
- 10:30-12:30 Phase III Studies
- 13:30-15:00 Phase I/II Studies
- 13:30-15:00 Clinical - New Agents
- 13:30-15:00 Clinical - Basic Biology - Research
- 15:30-17:30 Complete Response As A Marker Of Patient Outcomes (Sponsored by Millennium/Ortho-Biotech)
Complete Program Listing
|
|
Phase III Studies IFM, U.S. Europe, Others
|
|
|
XIIth International Myeloma Workshop in Washington, DCMario Boccadoro, M.D.
Ospedale San Giovanni Battista
Torino, Italy
|
|
|
|
|
XIIth International Myeloma Workshop in Washington, DCPieter Sonneveld, M.D.
University Hospital
Rotterdam, Netherlands
|
|
Oral Presentations – Clinical – Phase II/III Studies - I
|
|
|
XIIth International Myeloma Workshop in Washington, DCPaul Richardson, M.D.
Dana-Farber Cancer Institute
Boston, Massachusetts
|
|
|
|
|
XIIth International Myeloma Workshop in Washington, DCShaji Kumar, M.D.
Mayo Clinic
Rochester, Minnesota
|
|
|
|
|
XIIth International Myeloma Workshop in Washington, DCJean Luc Harousseau, M.D.
Hôpital Hotel Dieu
Nantes, France
|
|
|
|
|
XIIth International Myeloma Workshop in Washington, DCAntonio Palumbo, M.D.
Ospedale Molinette
Torino, Italy
|
|
|
|
|
XIIth International Myeloma Workshop in Washington, DC
Pierre Wijermans, M.D.
University Hospital
Rotterdam, Netherlands
|
|
|
|
|
XIIth International Myeloma Workshop in Washington, DCPieter Sonneveld, M.D.
University Hospital
Rotterdam, Netherlands
|
|
|
print
back to top